Corporate Banner
Satellite Banner
Technology Networks Header
Friday, April 25, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Optibrium, Integrated Chemistry Design Collaborate on New iPad App
Monday, March 17, 2014
Asteris for iPad enables drug discovery scientists to quickly explore high quality compound ideas.

GE Healthcare Launches High Performance Amersham™ Imager 600 Series
Monday, March 17, 2014
Superb imaging in chemiluminescence, fluorescence and colorimetric applications.

New PrimeSurface™ Culture Ware Now Available from Alpha Laboratories
Saturday, March 15, 2014
Ideal for spheroid cell colony formation.

Double O-ring Ensures High Integrity Cap Mat Seal
Thursday, March 13, 2014
New silicone cap mats from Porvair Sciences.

Hepregen Launches First Human HepatoPac™ Assay Kit
Thursday, March 13, 2014
Application-directed kit provides accurate information to developers of pharmaceuticals, cosmetics, and all new chemical entities.

SFU Completes Installation of Electron Microscopes from FEI
Tuesday, March 11, 2014
SFU’s new multi-million-dollar Centre for Soft Materials now offers the most advanced suite of microscopes in Western Canada.

Lab Relocation Specialist Expands Turnkey Solution
Friday, March 07, 2014
Specialist laboratory relocation expert, Andrew Porter Limited, has further expanded its service portfolio.

New HPLC Column Separates Challenging Glycan Isomers
Wednesday, March 05, 2014
Company will showcase the GlycanPac AXR-1 column at Pittcon 2014.

Hamilton Launches New Line of Benchtop Devices
Tuesday, March 04, 2014
The LabElite line provides flexible solutions for sample processing, tracking and security for automated and manual liquid handling workflows.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 2479
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv